Abstract
The effects of 1-piperonylpiperazine and N,alpha-dimethylpiperonylamine, which are weak inhibitors for [3H]5-hydroxytryptamine (5-HT) uptake, on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity were examined. The reductions of serotonergic parameters in the rat cerebral cortex produced by multiple administration of MDMA (10 mg/kg) were attenuated significantly by coadministration of 6-nitroquipazine (10 mg/kg), paroxetine (10 mg/kg) or 1-piperonylpiperazine (20 mg/kg), but not by N,alpha-dimethylpiperonylamine (20 mg/kg). The present data suggest that 1-piperonylpiperazine might inhibit the MDMA-induced neurotoxicity by effect(s) other than 5-HT uptake inhibition.
MeSH terms
-
3,4-Methylenedioxyamphetamine / analogs & derivatives*
-
3,4-Methylenedioxyamphetamine / antagonists & inhibitors
-
3,4-Methylenedioxyamphetamine / toxicity
-
Animals
-
Brain / drug effects*
-
Brain / metabolism
-
Hydroxyindoleacetic Acid / metabolism
-
Injections, Intraperitoneal
-
Male
-
N-Methyl-3,4-methylenedioxyamphetamine
-
Piperazines / pharmacology*
-
Quipazine / analogs & derivatives
-
Quipazine / pharmacology
-
Rats
-
Rats, Wistar
-
Selective Serotonin Reuptake Inhibitors / pharmacology*
-
Serotonin / metabolism
-
Serotonin Antagonists / pharmacology
Substances
-
Piperazines
-
Serotonin Antagonists
-
Serotonin Uptake Inhibitors
-
1-piperonylpiperazine
-
Serotonin
-
3,4-Methylenedioxyamphetamine
-
Quipazine
-
Hydroxyindoleacetic Acid
-
6-nitroquipazine
-
N-Methyl-3,4-methylenedioxyamphetamine